Cytokinetics, Incorporated (CYTK)
Market Closed
16 Oct, 08:00 PM
$
61. 95
-1.97
-3.082%
$
8.89B Market Cap
- P/E Ratio
- Div Yield
1.2M Volume
-4.45 Eps
$ 63.92
Previous Close 
Want to track CYTK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytokinetics, Incorporated (CYTK) Statistics
Valuation metrics
Market Cap 8.89B
Enterprise value 9.63B
Trailing P/E (ttm) -8.59
Forward P/E -
PEG ratio 0.26
Price/Sales (ttm) 121.37
Price/Book (mrq) -47.17
Enterprise Value/Revenue 135.68
Enterprise Value/EBITDA -11.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.78M
Average volume (90 days) 1.97M
Price summary
52-Week low 54.3
52-Week high 88.31
Beta -
50-Day moving average 67.53
200-Day moving average 73.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 25 Jun 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -12.6%
Operating margin -9.93%
Operational effectiveness
Return on assets -0.46%
Return on equity 1.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.54
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.83
Total debt (mrq) -
Total Debt/Equity (mrq) -7.32
Current ratio (mrq) 6.66%
Book value per share (mrq) -1.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
